Macrogenics Inc
(NAS:MGNX)
$
3.06
-0.22 (-6.71%)
Market Cap: 191.93 Mil
Enterprise Value: 100.36 Mil
PE Ratio: 0
PB Ratio: 3.33
GF Score: 51/100 MacroGenics Inc at Credit Suisse Healthcare Conference (Virtual) Transcript
Nov 10, 2020 / 07:45PM GMT
Release Date Price:
$21.21
(+5.05%)
Evan David Seigerman;dit Suisse AG
CrÃ;Research Division - VP & Senior Equity Research Analyst
© -
Hi there. There we go. Welcome, everybody, to the second day of the Crédit Suisse Global Virtual Healthcare Conference. We're looking forward to hopefully having everyone in person next year, but for now, Zoom will have to suffice. With me in the afternoon sessions today, we have MacroGenics. And from MacroGenics, it's my pleasure to introduce Scott Koenig, President and CEO. Scott, take it away.
Scott Koenig
MacroGenics, Inc. - CEO, President & Director
Thank you so much, Evan. I appreciate the invitation today. Let me get moving here. We're having problems advancing the slides. Just let me see what's going on here. There we go.
(technical difficulty)
Evan David Seigerman;dit Suisse AG;Scott Koenig
CrÃ;Research Division - VP & Senior Equity Research Analyst;MacroGenics, Inc. - CEO, President &
© -
There we go.
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot